Search

Howard B Urnovitz

from Iowa City, IA
Age ~71
Get Report
Also known as:
Howard Dr Urnovitz, Howard E Urnovitz, Howard B Ornovitz, Bruce Urnovitz Howard, Howard Z, Howard E
Phone and address:
511 Clark St, Iowa City, IA 52240
Related to:
Al UrnovitzSteven F Urnovitz, 67Anthony J Davis, 60Jackie A Davis, 55F DavisAnna M Davis, 69Al UrnovitzJohn T Davis, 75John A RecendevSteve Davis, 73Leola F DavisSteve T Davis, 66
Connected to:
Anthony M Uro, 55John Z Urogdy, 65Megan Urogi, 48Jason M Uronis, 45Bushra Urooj, 39Evelyn B Urosek, 87Rachel Urosek, 45Steve Urosevich, 103Tamara Urosevic, 31Vojin Urosevic, 64

Howard Urnovitz Phones & Addresses

  • 511 Clark St, Iowa City, IA 52240
  • Coralville, IA
  • San Jose, CA
  • San Francisco, CA
  • Alameda, CA
  • 783 22Nd Ave, San Francisco, CA 94121

Work

Company: Chronix biomedical Apr 2001 Address: San Jose, CA and Göttingen, Germany Position: Ceo

Education

Degree: PhD School / High School: University of Michigan 1975 to 1979 Specialities: Microbiology and Immunology

Skills

Biotechnology • Lifesciences • Cancer • Immunology • Genomics • Molecular Biology • Infectious Diseases • Intellectual Property • Bioinformatics • Cancer Research

Languages

German

Awards

Nyse/euronext market opening • London stock exchange market open

Industries

Biotechnology

Resumes

Resumes

Howard Urnovitz Photo 1

Chief Executive Officer

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Chronix Biomedical - San Jose, CA and Göttingen, Germany since Apr 2001
CEO
Calypte Biomedical Jun 1988 - Mar 2001
Founder, Chief Science Officer, Director
Washington University School of Medicine Jun 1979 - Jun 1981
Post-doctoral Fellow
Education:
University of Michigan 1975 - 1979
PhD, Microbiology and Immunology University of Michigan 1974 - 1975
MS, Microbiology and Immunology University of Michigan 1971 - 1974
BS, Honors College
Skills:
Biotechnology
Lifesciences
Cancer
Immunology
Genomics
Molecular Biology
Infectious Diseases
Intellectual Property
Bioinformatics
Cancer Research
Languages:
German
Awards:
NYSE/Euronext Market opening
https://exchanges.nyx.com/en/nyse-euronext-paris/invescore-roadshow-nyse-euronext-opens-european-trading-day-paris
London Stock Exchange Market Open
http://www.londonstockexchange.com/companies-and-advisors/news-events/welcome/invescore.htm

Business Records

Name / Title
Company / Classification
Phones & Addresses
Howard Urnovitz
President
CHRONIX BIOMEDICAL, INC
Mfg Diagnostic Substances
5941 Optical Ct SUITE 203E, San Jose, CA 95138
Howard B. Urnovitz
President
The Urnovitz Group, Inc
1440 4 St, Berkeley, CA 94710

Publications

Us Patents

Diagnostic Detection Of Nucleic Acids

View page
US Patent:
6344317, Feb 5, 2002
Filed:
Oct 3, 1997
Appl. No.:
08/943607
Inventors:
Howard B. Urnovitz - San Francisco CA
Assignee:
Chronix Biomedical, Inc. - San Francisco CA
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 536 235, 536 241, 536 2431, 536 2432, 536 2433
Abstract:
This invention provides sensitive nucleic acid hybridization assay methods for the detection of target human nucleic acids in a biological sample, such as acellular fluids. The methods are particularly useful in early diagnosis of chronic illnesses.

Detection Of Nucleic Acids To Assess Risk For Bovine Spongiform Encephalopathy

View page
US Patent:
7368243, May 6, 2008
Filed:
Jul 8, 2005
Appl. No.:
11/178246
Inventors:
Ekkehard Schuetz - Gottingen, DE
Leonid Iakoubov - San Ramon CA, US
Howard Urnovitz - Iowa City IA, US
Assignee:
Chronix Biomedical - San Jose CA
International Classification:
C12Q 1/68
C12P 19/34
C07H 21/02
C07H 21/04
US Classification:
435 6, 435 912, 536 231, 536 243
Abstract:
The present invention provides a method of detecting abnormal serum nucleic acid profiles to assess the risk of a transmissible spongiform encephalopathy, e. g. , BSE.

Methods For Generating An Mrna Expression Profile From An Ecellular Mrna Containing Blood Sample And Using The Same To Identify Functional State Markers

View page
US Patent:
20030036077, Feb 20, 2003
Filed:
May 31, 2002
Appl. No.:
10/161101
Inventors:
Alex Chenchik - Palo Alto CA, US
Leonid Iakoubov - Pleasanton CA, US
Howard Urnovitz - San Francisco CA, US
Assignee:
Chronix Biomedical - Benecia CA
International Classification:
C12Q001/68
C07H021/02
C12P019/34
US Classification:
435/006000, 536/023100, 536/024300, 435/091200
Abstract:
Methods for generating an mRNA expression profile are provided. In the subject methods, a population of nucleic acid targets is first generated from an acellular blood sample that contains a plurality of distinct mRNAs, i.e., a disease specific particular blood fraction. The resultant nucleic acid targets are hybridized to an array of nucleic acid probes to obtain an mRNA expression profile. The subject mRNA expression profiles are useful in the identification of disease specific markers. In such applications, the mRNA expression profiles are compared to a control expression profile to identify disease specific markers, where the identified markers subsequently find use in diagnostic applications. The subject methods also find use in diagnostic applications, where the mRNA expression profile is compared to a reference in making a diagnosis of the presence of a disease condition. Finally, kits for use in practicing the various methods are provided.

Methods For Generating An Mrna Expression Profile From An Acellular Mrna Containing Blood Sample And Using The Same To Identify Functional State Markers

View page
US Patent:
20030068642, Apr 10, 2003
Filed:
Nov 5, 2002
Appl. No.:
10/288746
Inventors:
Howard Urnovitz - San Francisco CA, US
Assignee:
Chronix Biomedical - Benecia CA
International Classification:
C12Q001/68
C07H021/04
US Classification:
435/006000, 536/024300
Abstract:
Methods for generating an mRNA expression profile are provided. In the subject methods, a population of nucleic acid targets is first generated from an acellular blood sample that contains a plurality of distinct mRNAs, i.e., a disease specific particular blood fraction. The resultant nucleic acid targets are hybridized to an array of nucleic acid probes to obtain an mRNA expression profile. The subject mRNA expression profiles are useful in the identification of disease specific markers. In such applications, the mRNA expression profiles are compared to a control expression profile to identify disease specific markers, where the identified markers subsequently find use in diagnostic applications. The subject methods also find use in diagnostic applications, where the mRNA expression profile is compared to a reference in making a diagnosis of the presence of a disease condition. Finally, kits for use in practicing the various methods are provided.

Diagnostic Detection Of Nucleic Acids

View page
US Patent:
20030077588, Apr 24, 2003
Filed:
Sep 19, 2001
Appl. No.:
09/957215
Inventors:
Howard Urnovitz - San Francisco CA, US
Assignee:
Chronix Biomedical, Inc - San Francisco CA
International Classification:
C12Q001/68
C12P019/34
US Classification:
435/006000, 435/091200
Abstract:
This invention provides sensitive nucleic acid hybridization assay methods for the detection of target human nucleic acids in a biological sample, such as acellular fluids. The methods are particularly useful in early diagnosis of chronic illnesses.

Diagnostic Detection Of Nucleic Acids

View page
US Patent:
20030082644, May 1, 2003
Filed:
Apr 1, 2002
Appl. No.:
10/115278
Inventors:
Ekkehard Schuetz - Goettingen, DE
Howard Urnovitz - San Francisco CA, US
Assignee:
Chronix Biomedical - Benicia CA
International Classification:
G01N033/567
US Classification:
435/007210
Abstract:
This invention provides sensitive nucleic acid hybridization assay methods for the detection of target animal nucleic acids in a biological sample, such as acellular fluids. The methods are particularly useful in early diagnosis of animal diseases, particularly chronic illnesses.

Diagnostic Detection Of Nucleic Acids

View page
US Patent:
20040241712, Dec 2, 2004
Filed:
Jan 21, 2004
Appl. No.:
10/762966
Inventors:
Ekkehard Schuetz - Goettingen, DE
Howard Urnovitz - San Francisco CA, US
Assignee:
Chronix Biomedical Inc. - San Jose CA
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
This invention provides sensitive nucleic acid hybridization assay methods for the detection of target animal nucleic acids in a biological sample, such as acellular fluids. The methods are particularly useful in early diagnosis of animal diseases, particularly chronic illnesses.

Detection Of Nucleic Acids To Assess Risk For Creutzfeldt-Jakob Disease

View page
US Patent:
20060099621, May 11, 2006
Filed:
Oct 7, 2005
Appl. No.:
11/245514
Inventors:
Ekkehard Schuetz - Gottingen, DE
Leonid Iakoubov - Pleasanton CA, US
Howard Urnovitz - Iowa City IA, US
Assignee:
Chronix Biomedical - San Jose CA
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435006000, 435091200
Abstract:
The present invention provides a method of detecting abnormal circulating nucleic acid profiles to assess the risk of Creutzfeldt-Jakob Disease.
Control profile
Howard B Urnovitz from Iowa City, IA, age ~71 Get Report